conclusion
Last reviewed 01/2018
None of the patients in the surveillance program benefitted.
The cost in time and money was large.
Most patients with Barrett's oesophagus die of unrelated conditions.
GPnotebook no longer supports Internet Explorer. To ensure the site functions as intended, please
upgrade your browser. Microsoft is encouraging users to upgrade to its more modern
Edge browser for improved security and functionality.